The Mulligan Law Firm is Evaluating Reglan® Injury Cases and Tardive dyskinesia

The Mulligan Law Firm is Evaluating Reglan® Injury Cases and Tardive dyskinesia

The Mulligan Law Firm announces that it is evaluating and investigating cases where usage of the prescription drug Reglan® has led to the development of a serious condition called Tardive dyskinesia.

Dallas, TX (Advertiser Talk) 30-Jul-2009 — The Mulligan Law Firm (http://www.mulliganlaw.com) has started evaluating possible Reglan® injury claims and links with the development of a serious side-effect: Tardive dyskinesia.

Reglan® (which has the generic name of metoclopramide) is a prescribed medication that is designed for the treatment of gastroesophageal reflux in the short-term.

The development of Tardive dyskinesia – a neurological condition – has been reported in a number of patients whose doctors have prescribed Reglan® for the treatment of gastroesophageal reflux.

Specific details can be found at the official website of the U.S. Food & Drug Administration at the following FDA link: http://www.fda.gov/bbs/topics/NEWS/2009/NEW01963.html

People who have developed Tardive dyskinesia after taking Reglan® should contact The Mulligan Law Firm immediately. The Mulligan Law Firm is very interested in speaking with any Reglan® patients who have been affected by Tardive dyskinesia.

The symptoms associated with Tardive dyskinesia are extremely distressing, and can include uncontrollable movement in the legs, arms, feet and hands; protrusion of the tongue; involuntary and rapid blinking of the eyes; and uncontrolled grimacing.

The Mulligan Law Firm is now offering a free evaluation and investigation of potential claims related to patients who may have developed Tardive dyskinesia after taking Reglan®.

Those who have developed Tardive dyskinesia after being prescribed Reglan®, should contact The Mulligan Law Firm as soon as possible to discuss a potential claim.

The attorneys of The Mulligan Law Firm emphasize that in personal injury cases and lawsuits involving Reglan® and Tardive dyskinesia, it is vital that steps are taken to preserve all available evidence, and to allow physicians and/or other expert witnesses to thoroughly evaluate any and all potential injuries.

Moreover, current statutes of limitations require potential plaintiffs to act within certain, established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing rights.

Do not delay: contact The Mulligan Law Firm today about Reglan® and Tardive dyskinesia.

About The Mulligan Law Firm:

The Mulligan Law Firm was formed in 1995. The firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600 million U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

The Mulligan Law Firm would like to hear from Reglan® patients that have been affected by Tardive dyskinesia.

Reglan® is a registered trademark of Schwartz Pharma, Inc.

For more information on Reglan® and Tardive dyskinesia and The Mulligan Law Firm, see the website: http://www.mulliganlaw.com

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evauating nationwide claims.

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

Patrick J. Mulligan, Attorney / Lawyer* Eric W. Gruenwald, Attorney / Lawyer+ The Mulligan Law Firm 214-219-9779, EXT. 245

*Licensed in Texas & Georgia +Licensed in California only

##

PRWEB